Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) still is a big burden for China. In recent years, the third-generation platinum compounds have been proposed as potential active agents for HCC. However, more experimental and clinical data are warrante...
Main Authors: | Chen Chang-Jie, Teng Feng-Meng, Qin Shu-Kui, Wu Qiong, Wang Rui |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/3/1/43 |
Similar Items
-
Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer
by: Liyan Gu, et al.
Published: (2019-02-01) -
ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
by: Yuanfei Deng, et al.
Published: (2022-05-01) -
Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
by: Huan Wang, et al.
Published: (2021-03-01) -
SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma
by: Jing Lin, et al.
Published: (2023-01-01) -
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma
by: Alessandra Scagliola, et al.
Published: (2023-03-01)